Integral Health Asset Management
Latest statistics and disclosures from Integral Health Asset Management's latest quarterly 13F-HR filing:
- Top 5 stock holdings are CI, ZBH, Novo-nordisk A S option, INSP, MCK, and represent 24.62% of Integral Health Asset Management's stock portfolio.
- Added to shares of these 10 stocks: CI (+$51M), ZBH (+$44M), Novo-nordisk A S option (+$41M), MCK (+$31M), THC (+$19M), BSX (+$17M), MLTX (+$15M), EHC (+$15M), LLY (+$14M), CNC (+$14M).
- Started 33 new stock positions in SDGR, TEVA, CCRN, MDT, BNTX, NVS, ZBH, ABC, TDOC, SIBN.
- Reduced shares in these 10 stocks: SYK (-$14M), TFX (-$12M), , , Sarepta Therapeutics Inc. cmn (-$10M), QURE (-$10M), , HUM (-$9.7M), , ELV (-$9.3M).
- Sold out of its positions in ACHC, ACRS, Aclaris Therapeutics Inc call, AGIO, ALGN, BAX, BIIB, CAH, CTLT, KDNY.
- Integral Health Asset Management was a net buyer of stock by $283M.
- Integral Health Asset Management has $808M in assets under management (AUM), dropping by 62.69%.
- Central Index Key (CIK): 0001773206
Tip: Access up to 7 years of quarterly data
Positions held by Integral Health Asset Management consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Portfolio Holdings for Integral Health Asset Management
Integral Health Asset Management holds 73 positions in its portfolio as reported in the June 2023 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price | |
|---|---|---|---|---|---|---|
| Cigna Corp (CI) | 6.3 | $51M | NEW | 180k | 280.60 |
|
| Zimmer Holdings (ZBH) | 5.4 | $44M | NEW | 300k | 145.60 |
|
| Novo-nordisk A S Put Put Option | 5.0 | $41M | NEW | 250k | 161.83 |
|
| Inspire Med Sys (INSP) | 4.1 | $33M | +28% | 103k | 324.64 |
|
| McKesson Corporation (MCK) | 3.8 | $31M | NEW | 72k | 427.31 |
|
| Boston Scientific Corporation (BSX) | 3.1 | $25M | +206% | 466k | 54.09 |
|
| Cytokinetics Com New (CYTK) | 2.6 | $21M | +8% | 650k | 32.62 |
|
| Cooper Cos Com New (COO) | 2.5 | $20M | +30% | 52k | 383.43 |
|
| Tenet Healthcare Corp Com New (THC) | 2.3 | $19M | NEW | 232k | 81.38 |
|
| PerkinElmer (RVTY) | 2.1 | $17M | +64% | 140k | 118.79 |
|
| Argenx Se Sponsored Adr (ARGX) | 1.9 | $16M | +233% | 40k | 389.73 |
|
| Moonlake Immunotherapeutics Class A Ord (MLTX) | 1.9 | $15M | NEW | 300k | 51.00 |
|
| Encompass Health Corp (EHC) | 1.8 | $15M | NEW | 220k | 67.71 |
|
| Guardant Health (GH) | 1.8 | $15M | +17% | 412k | 35.80 |
|
| Hologic (HOLX) | 1.8 | $14M | +133% | 175k | 80.97 |
|
| Eli Lilly & Co. (LLY) | 1.7 | $14M | NEW | 30k | 468.98 |
|
| Centene Corporation (CNC) | 1.7 | $14M | NEW | 200k | 67.45 |
|
| Abbvie (ABBV) | 1.7 | $14M | +23% | 100k | 134.73 |
|
| Anthem (ELV) | 1.7 | $13M | -41% | 30k | 444.29 |
|
| Schrodinger (SDGR) | 1.6 | $13M | NEW | 265k | 49.92 |
|
| Zentalis Pharmaceuticals (ZNTL) | 1.6 | $13M | -25% | 450k | 28.21 |
|
| GSK Sponsored Adr (GSK) | 1.5 | $13M | NEW | 350k | 35.64 |
|
| Intuitive Surgical Com New (ISRG) | 1.5 | $12M | NEW | 36k | 341.94 |
|
| Reata Pharmaceuticals Cl A (RETA) | 1.5 | $12M | +69% | 120k | 101.96 |
|
| Hca Holdings (HCA) | 1.5 | $12M | -11% | 40k | 303.48 |
|
| Danaher Corporation (DHR) | 1.5 | $12M | NEW | 50k | 240.00 |
|
| Johnson & Johnson (JNJ) | 1.5 | $12M | NEW | 72k | 165.52 |
|
| Viking Therapeutics (VKTX) | 1.5 | $12M | 730k | 16.21 |
|
|
| Ventyx Biosciences (VTYX) | 1.4 | $12M | +20% | 350k | 32.80 |
|
| Surgery Partners (SGRY) | 1.4 | $11M | +104% | 250k | 44.99 |
|
| Novartis Sponsored Adr (NVS) | 1.3 | $10M | NEW | 103k | 100.91 |
|
| Replimune Group (REPL) | 1.3 | $10M | +12% | 445k | 23.22 |
|
| Penumbra (PEN) | 1.3 | $10M | -14% | 30k | 344.06 |
|
| Alnylam Pharmaceuticals (ALNY) | 1.2 | $9.9M | +160% | 52k | 189.94 |
|
| Revolution Medicines (RVMD) | 1.2 | $9.5M | +3% | 356k | 26.75 |
|
| Inari Medical Ord (NARI) | 1.1 | $9.0M | +55% | 155k | 58.14 |
|
| Intra Cellular Therapies (ITCI) | 1.1 | $9.0M | NEW | 142k | 63.32 |
|
| Alkermes SHS (ALKS) | 1.1 | $8.9M | +58% | 284k | 31.30 |
|
| Relay Therapeutics (RLAY) | 1.1 | $8.8M | -9% | 700k | 12.56 |
|
| Intellia Therapeutics (NTLA) | 1.0 | $8.4M | NEW | 206k | 40.78 |
|
| EXACT Sciences Corporation (EXAS) | 1.0 | $8.3M | -45% | 88k | 93.90 |
|
| Teva Pharmaceutical Inds Sponsored Ads (TEVA) | 0.9 | $7.5M | NEW | 1.0M | 7.53 |
|
| Krystal Biotech (KRYS) | 0.9 | $7.3M | -27% | 62k | 117.40 |
|
| Ptc Therapeutics I (PTCT) | 0.9 | $7.1M | -2% | 174k | 40.67 |
|
| Lifestance Health Group (LFST) | 0.9 | $7.1M | +9% | 773k | 9.13 |
|
| Medtronic SHS (MDT) | 0.9 | $7.0M | NEW | 80k | 88.10 |
|
| Apellis Pharmaceuticals (APLS) | 0.8 | $6.6M | NEW | 72k | 91.10 |
|
| Revance Therapeutics (RVNC) | 0.8 | $6.3M | 250k | 25.31 |
|
|
| Tg Therapeutics (TGTX) | 0.8 | $6.2M | NEW | 250k | 24.84 |
|
| Si-bone (SIBN) | 0.8 | $6.1M | NEW | 227k | 26.98 |
|
| Crispr Therapeutics Namen Akt (CRSP) | 0.7 | $5.6M | 100k | 56.14 |
|
|
| Privia Health Group (PRVA) | 0.6 | $5.2M | NEW | 200k | 26.11 |
|
| Envista Hldgs Corp (NVST) | 0.6 | $5.1M | 150k | 33.84 |
|
|
| Teladoc (TDOC) | 0.6 | $5.1M | NEW | 200k | 25.32 |
|
| AmerisourceBergen (ABC) | 0.6 | $5.0M | NEW | 26k | 192.43 |
|
| Amicus Therapeutics (FOLD) | 0.6 | $4.9M | +26% | 387k | 12.56 |
|
| Longboard Pharmaceuticals In (LBPH) | 0.5 | $4.4M | +2% | 598k | 7.34 |
|
| Cross Country Healthcare (CCRN) | 0.5 | $4.4M | NEW | 155k | 28.08 |
|
| BioMarin Pharmaceutical (BMRN) | 0.5 | $4.3M | -50% | 50k | 86.68 |
|
| Dentsply Sirona (XRAY) | 0.5 | $4.0M | NEW | 100k | 40.02 |
|
| Biontech Se Sponsored Ads (BNTX) | 0.5 | $3.9M | NEW | 36k | 107.93 |
|
| Sage Therapeutics (SAGE) | 0.5 | $3.8M | -67% | 80k | 47.02 |
|
| Prothena Corp SHS (PRTA) | 0.4 | $3.6M | NEW | 52k | 68.28 |
|
| Akero Therapeutics (AKRO) | 0.4 | $3.3M | 70k | 46.69 |
|
|
| Walgreens Boots Alliance Call Call Option | 0.4 | $2.8M | NEW | 100k | 28.49 |
|
| Uniqure Nv Call Call Option | 0.3 | $2.3M | NEW | 200k | 11.46 |
|
| Supernus Pharmaceuticals (SUPN) | 0.3 | $2.3M | -40% | 75k | 30.06 |
|
| Keros Therapeutics (KROS) | 0.3 | $2.1M | +4% | 52k | 40.18 |
|
| Protagonist Therapeutics (PTGX) | 0.3 | $2.1M | NEW | 75k | 27.62 |
|
| Allogene Therapeutics (ALLO) | 0.3 | $2.0M | 412k | 4.97 |
|
|
| Elanco Animal Health (ELAN) | 0.2 | $2.0M | NEW | 200k | 10.06 |
|
| Terns Pharmaceuticals (TERN) | 0.2 | $1.6M | +80% | 180k | 8.75 |
|
| Dyne Therapeutics (DYN) | 0.1 | $698k | +8% | 62k | 11.25 |
|
Past Filings by Integral Health Asset Management
SEC 13F filings are viewable for Integral Health Asset Management going back to 2019
- Integral Health Asset Management 2023 Q2 filed Aug. 11, 2023
- Integral Health Asset Management 2023 Q1 filed May 9, 2023
- Integral Health Asset Management 2022 Q4 filed Feb. 13, 2023
- Integral Health Asset Management 2022 Q3 filed Nov. 14, 2022
- Integral Health Asset Management 2022 Q2 filed Aug. 3, 2022
- Integral Health Asset Management 2022 Q1 filed May 12, 2022
- Integral Health Asset Management 2021 Q4 filed Feb. 2, 2022
- Integral Health Asset Management 2021 Q3 filed Nov. 12, 2021
- Integral Health Asset Management 2021 Q2 restated filed Aug. 30, 2021
- Integral Health Asset Management 2021 Q2 filed Aug. 13, 2021
- Integral Health Asset Management 2021 Q1 filed May 10, 2021
- Integral Health Asset Management 2020 Q4 filed Feb. 16, 2021
- Integral Health Asset Management 2020 Q3 filed Nov. 16, 2020
- Integral Health Asset Management 2020 Q2 filed Aug. 14, 2020
- Integral Health Asset Management 2020 Q1 filed May 15, 2020
- Integral Health Asset Management 2019 Q4 filed Feb. 13, 2020